NKMax America Presents Promising Clinical Research Findings at 2020 ASCO Virtual Conference

NEXT STORY
Tempus’ TIME Trial™ Program Reaches Critical Scale and Operational Milestones
PREV STORY
Treos Bio Reports Positive Final Results of Phase I/II Off-The-Shelf CRC Cancer Immunotherapy in 2020 ASCO Poster Presentation
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Prelude Therapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

author_avatar
NASDAQ Market News

Kirkland Lake Gold Announces Filing of Amended and Restated Detour Lake Mine Technical Report

author_avatar
NASDAQ Market News

Abeona Therapeutics Issues Letter to Stockholders

author_avatar
NASDAQ Market News